Trollor Julian N, Salomon Carmela, Franklin Catherine
Department of Developmental Disability Neuropsychiatry, School of Psychiatry, UNSW Australia, Sydney.
Queensland Centre for Intellectual and Developmental Disability Mater Research Institute - University of Queensland, Brisbane.
Aust Prescr. 2016 Aug;39(4):126-130. doi: 10.18773/austprescr.2016.048. Epub 2016 Aug 1.
Mental illness is common in people with intellectual disability. They may also have physical health problems which can affect their mental state. Difficulties in communication can contribute to mental health problems being overlooked. These may present with changes in behaviour. Psychological management is usually preferable to prescribing psychotropic drugs. Behavioural approaches are the most appropriate way to manage challenging behaviour. If a drug is considered, prescribers should complete a thorough diagnostic assessment, exclude physical and environmental contributions to symptoms, and consider medical comorbidities before prescribing. Where possible avoid psychotropics with the highest cardiometabolic burden. Prescribe the minimum effective dose and treatment length, and regularly monitor drug efficacy and adverse effects. There is insufficient evidence to support the use of psychotropics for challenging behaviour. They should be avoided unless the behaviour is severe and non-responsive to other treatments.
精神疾病在智力残疾者中很常见。他们也可能有身体健康问题,这会影响他们的精神状态。沟通困难可能导致心理健康问题被忽视。这些问题可能表现为行为改变。心理管理通常比开精神药物更可取。行为方法是管理具有挑战性的行为的最合适方式。如果考虑使用药物,开处方者应进行全面的诊断评估,排除身体和环境对症状的影响,并在开处方前考虑合并症。尽可能避免使用心脏代谢负担最高的精神药物。开出最低有效剂量和治疗时长,并定期监测药物疗效和不良反应。没有足够的证据支持使用精神药物来应对具有挑战性的行为。除非行为严重且对其他治疗无反应,否则应避免使用。